| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |